Lupin Launches Ganirelix Acetate Injection in the United States
Leading global pharmaceutical company Lupin Limited (Lupin) has announced the introduction of Ganirelix Acetate Injection, 250 mcg mL, Single-Dose Prefilled Syringe, following approval from the United States Food and Drug…
Olezarsen receives Orphan Drug designation from U.S. FDA for familial chylomicronemia syndrome
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) revealed today that it has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for its experimental drug olezarsen. This designation is…
Initiative by WHO to Enhance Global Health Resilience through Biomanufacturing Workforce Training
The COVID-19 pandemic has brought to light the vulnerabilities inherent in global supply chains, especially affecting the access of low- and middle-income countries (LMICs) to crucial medical supplies. The disproportionate…
Revised WHO Recommendations for Managing Vector-Borne Diseases via Indoor Residual Spraying
Approximately 80% of the global population faces the threat of contracting one or more vector-borne diseases, with mosquitoes, flies, bugs, and other vectors transmitting viruses, parasites, and bacteria to millions…
WHO Unveils Guidelines and Resources to Improve Small-Scale Water Supplies
Today, the World Health Organization (WHO) has unveiled guidelines and tools aimed at enhancing small-scale water supplies. The newly introduced Guidelines for drinking water quality: small water supplies, along with…
ONO and Numab Forge Collaboration: Advancing Multi-specific Antibody NM49 through Option Agreement
Ono Pharmaceutical Co., Ltd. (Osaka, Japan), led by President and CEO Gyo Sagara, has announced a significant milestone today. The company has formalized an option and collaboration agreement with Numab…
Sarepta Therapeutics Receives U.S. FDA Acceptance for Efficacy Supplement Enabling Expansion of ELEVIDYS Indication
Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a pioneer in precision genetic medicine for rare diseases, has announced today that the U.S. Food and Drug Administration (FDA) has accepted and filed the…
Grifols Reveals Encouraging Phase 3 Fibrinogen Clinical Trial Findings
In the AdFirst trial, Biotest’s fibrinogen concentrate (FC), BT524, successfully met the primary endpoint, demonstrating its efficacy in treating acquired fibrinogen deficiency (AFD) on par with standard care, while maintaining…
Biogen Received European Commission Approval for SKYCLARYS® (omaveloxolone), the First Therapy to Treat Friedreich’s Ataxia
Today, GSK has announced the successful completion of its acquisition of Aiolos Bio (Aiolos), a clinical-stage biopharmaceutical company focused on addressing the unmet treatment needs of patients with respiratory and…
GSK Finalizes Acquisition of Aiolos Bio
Today marks the completion of GSK’s acquisition of Aiolos Bio (Aiolos), a clinical-stage biopharmaceutical company dedicated to addressing the unmet medical needs of patients with respiratory and inflammatory conditions. As…
Practical Two Day FDA Inspection Online Seminar – Research AndMarkets.com
ResearchAndMarkets.com is pleased to announce the addition of “FDA Inspection” training to its offerings. This two-day seminar is meticulously crafted to equip professionals in the pharmaceutical, biopharmaceutical, biologics, and medical…
Zoetis Reports Fourth Quarter and Full Year 2023 Results
Zoetis, a global leader in animal health, has announced its financial results for the fourth quarter and full year 2023, along with full-year guidance for 2024. In the fourth quarter…